Bleomycin Sulfate Injection shortage
To Be DiscontinuedBleomycin Sulfate Injection is currently listed as To Be Discontinued in the FDA Drug Shortage Database. Reported reason: Not specified.
Therapeutic category
Dosage form
Injection
Routes
INTRAMUSCULAR, INTRAPLEURAL, INTRAVENOUS, SUBCUTANEOUS
Last updated
06/13/2025
Strength variants
- Not specified
Need sourcing help for Bleomycin Sulfate Injection?
Get connected with licensed distributors and 503B compounders that can fulfill orders during active shortages. Verified suppliers, no spam.
Connect with a sourcing partnerManufacturers reporting shortage
- Hospira, Inc., a Pfizer Company844-646-4398To Be Discontinued
- Hospira, Inc., a Pfizer Company844-646-4398To Be Discontinued
Reason for shortage
ad slot 300x250
Related shortages in Hematology
Heparin Sodium Injection
- Category
- Hematology
- Reason
- Requirements related to complying with good manufacturing practices
- Updated
- 04/07/2026
Heparin Sodium Injection
- Category
- Hematology
- Reason
- Requirements related to complying with good manufacturing practices
- Updated
- 04/07/2026
Desmopressin Acetate Spray
- Category
- Hematology
- Reason
- Not specified
- Updated
- 04/02/2026
Heparin Sodium Injection
- Category
- Hematology
- Reason
- Not specified
- Updated
- 04/02/2026
Heparin Sodium Injection
- Category
- Hematology
- Reason
- Not specified
- Updated
- 04/02/2026
Heparin Sodium Injection
- Category
- Hematology
- Reason
- Discontinuation of the manufacture of the drug
- Updated
- 04/01/2026
This information is not medical advice. Consult your pharmacist. Data is sourced from the FDA Drug Shortage Database and may not reflect real-time inventory at your facility. ShortageWatch is independent and not affiliated with the FDA.